W. R. Berkley Corporation’s Board of Directors has approved an increase in the Company’s common stock repurchase authorization to 25 million shares. This move reinforces management’s commitment to enhancing shareholder value through both organic growth and capital return initiatives. Repurchases will be executed opportunistically in the open market or through privately negotiated transactions, subject to prevailing market conditions. Since its founding in 1967, Berkley has grown into one of the largest commercial lines writers in the U.S., operating two primary segments: Insurance and Reinsurance & Monoline Excess. The expanded buyback capacity provides the company with greater flexibility to deploy excess capital while continuing to build book value over time.

Evercore ISI downgraded W. R. Berkley from In Line to Underperform, forecasting approximately 4% downside to consensus EPS estimates for 2026–2027. The firm highlighted rising loss ratios as Berkley has adopted more conservative reserving assumptions, and warned of slower growth across key liability lines, including excess & surplus small liability and workers’ compensation. Analysts also pointed to $485 million of adverse development on accident years 2022 and earlier recorded through Q3 2025, partially offset by favorable adjustments in more recent underwriting periods. While no net adverse prior-year development is expected in 2026, ongoing conservative reserving could pressure current-year loss ratios and lead to negative estimate revisions. Evercore further noted that maintaining rate discipline in challenged casualty lines may force volume trade-offs, potentially dampening top-line expansion.